Review
Open access
Aug 2026
Organization from cell to tissue derived delivery systems for immunotherapy
Dysregulation of the immune system drives a broad spectrum of diseases, including cancers, autoimmune disorders, and neuro-immune conditions. Immunotherapy has advanced from small-molecule drugs to biomacromolecular agents and living cell therapies, yet conventional synthetic delivery platforms struggle to preserve the...
Xi Tan, Mutang Li, Dan-Dan Luo et al.
· Materials Today Bio · 0 citations